What is Health Catalyst's R&D?

Health Catalyst (HCAT) reported R&D of $9.78M in Q1 2026.

How has Health Catalyst's R&D changed year-over-year?

Health Catalyst's R&D decreased by 35.6% year-over-year, from $15.19M to $9.78M.

What is the long-term trend for Health Catalyst's R&D?

Over 4 years (2021 to 2025), Health Catalyst's R&D has grown at a -5.6% compound annual growth rate (CAGR), from $62.73M to $49.77M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Health Catalyst HCAT R&D

R&D at other companies

International Business MachinesIBM

$2.17B+11.4%

Spok HoldingsSPOK

$3.46M+11.7%

OracleORCL

$2.61B-1.5%

Definitive Healthcare Corp.DH

$6.5M-30.1%

CareCloud, Inc.CCLD

$2.42M+95.6%

Tandem Diabetes CareTNDM

$46.04M-8.3%

Other financials

Income statement

See full

Revenue$70.8M-10.9%

Gross profit$35.5M-2.1%

Operating income-$106.5M-428%

Net income-$111.0M-368%

EPS (diluted)-$1.53-337%

Balance sheet

See full

Cash & equivalents$59.9M-82.5%

Total debt$170.6M-57.6%

Total equity$138.1M-63.3%

Total assets$412.2M-53.8%

Cash flow

See full

Operating cash flow$18.5M+6,511%

CapEx$338.0K-49.6%

Free cash flow$18.2M+4,760%

Valuation

See full

Market cap$147.05M-41.0%

Enterprise value$257.76M-30.9%

P/S0.5×-0.3×

Profitability

See full

Gross margin49.9%+4.7pp

Operating margin-81.7%-127pp

Net margin-87.7%-138pp

FCF margin-0.8%-0.4pp

Returns & leverage

See full

Return on equity-103%-135pp

Debt / equity1.2×+0.2×

Current ratio1.7×+0.4×

Where this comes from

Reported directly by Health Catalyst in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Health Catalyst’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Health Catalyst's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Health Catalyst's R&D?: Health Catalyst (HCAT) reported R&D of $9.78M in Q1 2026.
How has Health Catalyst's R&D changed year-over-year?: Health Catalyst's R&D decreased by 35.6% year-over-year, from $15.19M to $9.78M.
What is the long-term trend for Health Catalyst's R&D?: Over 4 years (2021 to 2025), Health Catalyst's R&D has grown at a -5.6% compound annual growth rate (CAGR), from $62.73M to $49.77M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.